New-onset Chronic Pelvic Pain in Transgender People Using Testosterone Therapy: an Exploratory Qualitative Study.

Recruiting Observational Study
Transgender Persons Pelvic Pain Testosterone Gender-Affirming Care
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
15 (estimated)
Sponsor
University Hospital, Grenoble · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This descriptive qualitative study aim to describe the characteristics of pelvic pain in transgender (trans) individuals using testosterone therapy and the impact on their quality of life. This study also aim to understand the levers and obstacles to consulting a health care professional.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Being a trans masculine individual * Taking a gender affirming hormonal therapy (GAHT) * living close to Grenoble * having pelvic pain that appeared or were modified after taking GAHT Exclusion Criteria: * Subject under guardianship or subject deprived of liberty Refusal of …
Contacts

SaraEve Graham Longsworth, MSc

+33646820783

CONTACT